Literature DB >> 16376440

Dysautonomia and ventricular dysfunction in the indeterminate form of Chagas disease.

Roberta B G Molina1, Beatriz B Matsubara, João C Hueb, Silméia Garcia Zanati, Domingos A Meira, José Luiz Cassolato, Sergio A R Paiva, Leonardo A M Zornoff.   

Abstract

BACKGROUND: The associations between autonomic function and biventricular function in patients with the indeterminate form of Chagas disease remains to be elucidated.
METHODS: In 42 asymptomatic patients and 19 healthy volunteers, the autonomic function was assessed by time domain indices of heart rate variability (HRV), analyzed for 24 h; the right ventricular function was assessed by fraction area change, right ventricle shortening, and systolic excursion of the tricuspid valve; and the left ventricular function was assessed by ejection fraction and transmitral flow velocities. Data were expressed as mean+/-SD or medians (including the lower quartile and upper quartile). Groups were compared by Student's t or Mann-Whitney U test. Autonomic and ventricular function were correlated by Pearson's or Spearman's correlation coefficient. The level of significance was 5%.
RESULTS: Right and left ventricular systolic function indexes were comparable between groups. Transmitral flow velocities were decreased in the Chagas disease group (p<0.05). The patients presented impaired HRV as indicated by the values of SDNN-day (80 (64-99) ms vs. 98 (78-127) ms; p=0.045), SDNNI-24 h (54 (43-71) vs. 65 (54-105) ms; p=0.027), SDNNI-day (49 (42-64) vs. 67 (48-76) ms; p=0.045), pNN50-day (2.2 (0.7-5)% vs. 10 (3-11)%; p=0.033); and pNN50-24 h (3 (1-7)% vs. 12 (8-19)%; p=0.013). There were no correlations between the left ventricular diastolic indices and autonomic dysfunctional indices (p>0.05).
CONCLUSION: Patients with the indeterminate form of Chagas disease have both dysautonomia and left ventricular diastolic dysfunction. However, the right ventricular function is preserved. Importantly, ventricular diastolic dysfunction and dysautonomia are independent phenomena.

Entities:  

Mesh:

Year:  2006        PMID: 16376440     DOI: 10.1016/j.ijcard.2005.11.010

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

Review 2.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

3.  Enhanced parasympathetic activity in Chagas disease still stands in need of proof.

Authors:  Antonio Luiz P Ribeiro; Antonio Carlos Campos de Carvalho; Federico Lombardi; Mauro Martins Teixeira; Manoel Otávio Costa Rocha
Journal:  Int J Cardiol       Date:  2008-07-03       Impact factor: 4.164

4.  Autonomic dysfunction and risk factors associated with Trypanosoma cruzi infection among children in Arequipa, Peru.

Authors:  Natalie M Bowman; Vivian Kawai; Robert H Gilman; Cesar Bocangel; Gerson Galdos-Cardenas; Lilia Cabrera; Michael Z Levy; Juan Geny Cornejo del Carpio; Freddy Delgado; Lauren Rosenthal; Vivian V Pinedo-Cancino; Francis Steurer; Amy E Seitz; James H Maguire; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

Review 5.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

6.  Dysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels.

Authors:  João Marcos Barbosa-Ferreira; Charles Mady; Barbara Maria Ianni; Heno Ferreira Lopes; Felix José Alvarez Ramires; Vera Maria Cury Salemi; Cesar José Grupi; Denise Tessariol Hachul; Fábio Fernandes
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Utility of a novel risk score for prediction of ventricular tachycardia and cardiac death in chronic Chagas disease - the SEARCH-RIO study.

Authors:  P R Benchimol-Barbosa; B R Tura; E C Barbosa; B K Kantharia
Journal:  Braz J Med Biol Res       Date:  2013-10-22       Impact factor: 2.590

8.  Heart rate recovery in asymptomatic patients with Chagas disease.

Authors:  Maria Clara Noman de Alencar; Manoel Otávio da Costa Rocha; Márcia Maria de Oliveira Lima; Henrique Silveira Costa; Giovane Rodrigo Sousa; Renata de Carvalho Bicalho Carneiro; Guilherme Canabrava Rodrigues Silva; Fernando Vieira Brandão; Lucas Jordan Kreuser; Antonio Luiz Pinho Ribeiro; Maria Carmo Pereira Nunes
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

9.  Effects of exercise training on heart rate variability in Chagas heart disease.

Authors:  Bruno Ramos Nascimento; Márcia Maria Oliveira Lima; Maria do Carmo Pereira Nunes; Maria Clara Noman de Alencar; Henrique Silveira Costa; Marcelo Martins Pinto Filho; Vitor Emanuel Serafim Cota; Manoel Otávio da Costa Rocha; Antonio Luiz Pinho Ribeiro
Journal:  Arq Bras Cardiol       Date:  2014-08-01       Impact factor: 2.000

10.  Etanercept induces low QRS voltage and autonomic dysfunction in mice with experimental Chagas disease.

Authors:  Héctor Rodríguez-Angulo; Oscar García; Endher Castillo; Edward Cardenas; Juan Marques; Alfredo Mijares
Journal:  Arq Bras Cardiol       Date:  2013-07-23       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.